[en] Creutzfeldt-Jakob disease (CJD) is a rare and fatal neurodegenerative disease of unknown cause. Patients are usually aged between 50 and 75 and typical clinical features include rapidly progressive dementia associated with myoclonus and a characteristic electroencephalographic pattern. Neuropathological examination reveals cortical spongiform change, hence the term 'spongiform encephalopathy'. Several statistical techniques were applied to classify patients with sporadic CJD (sCJD), based on clinical and neuropathological investigation. We focus on the classification of neuropathologically confirmed sCJD patients. In order to obtain a classification rule that correctly classifies this type of patients and at the same time controls the overall error rate, we apply several classification techniques, which in general, produce comparable results. The boosting method produces the best results and the variable 14-3-3 protein in cerebrospinal fluid plays the most important role in the prediction of neuropathologically confirmed sCJD.
Disciplines :
Public health, health care sciences & services
Author, co-author :
Abrahantes, J. C.
Aerts, M.
van Everbroeck, B.
Saegerman, Claude ; Université de Liège - ULiège > Département des maladies infectieuses et parasitaires > Epidémiologie et analyse des risques appl. aux sc. vétér.
Berkvens, D.
Geys, H.
Mintiens, K.
Roels, S.
Cras, P.
Language :
English
Title :
Classification of sporadic Creutzfeldt-Jakob disease based on clinical and neuropathological characteristics
Prusiner SB. Prions. Proc Natl Acad Sci USA 1998;95:13363-83.
Prusiner SB. Prions are novel infectious pathogens causing scrapie and Creutzfeldt-Jakob disease. Bioessays 1986;5:281-6.
Van Everbroeck B, Pals P, Martin JJ, Cras P. Transmissible spongiform encephalopathies: the story of a pathogenic protein. Peptides 2002;23:1351-9.
Zeidler M, Green A. Advances in diagnosing Creutzfeldt-Jakob disease with MRI and CSF 14-3-3 protein analysis. Neurology 2004;63:410-1.
Van Everbroeck B, Pals P, Dziedzic T, Dom R, Godfraind C, Sciot R, et al. Retrospective study of Creutzfeldt-Jakob disease in Belgium: neuropathological findings. Acta Neuropathol (Berl) 2000;99:358-64.
Will RG, Matthews WB. A retrospective study of Creutzfeldt-Jakob disease in England and Wales 1970-79. I: Clinical features. J Neurol Neurosurg Psychiatry 1984;47:134-40.
Brown P, Gibbs CJ Jr, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-29.
Poser S, Mollenhauer B, Kraubeta A, et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999;122(Pt 12):2345-51.
Zerr I, Schulz-Schaeffer WJ, Giese A, Bodemer M, Schroter A, Henkel K, et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000;48:323-9.
Van Everbroeck B, Pals P, Quoilin S, Martin JJ, Cras P. The many faces of human prion diseases in Belgium and the world. Acta Neurol Belg 2001;101:81-7.
Collins S, Boyd A, Fletcher A, Gonzales MF, McLean CA, Masters CL. Recent advances in the pre-mortem diagnosis of Creutzfeldt-Jakob disease. J Clin Neurosci 2000;7:195-202.
Zerr I, Pocchiari M, Collins S, Brandel JP, de Pedro Cuesta J, Knight RS, et al. Analysis of EEG and CSF 14-3-3 proteins as aids to the diagnosis of Creutzfeldt-Jakob disease. Neurology 2000;55:811-5.
Van Everbroeck B, Dobbeleir I, De Waele M, De Deyn P, Martin JJ, Cras P. Differential diagnosis of 201 possible Creutzfeldt-Jakob disease patients. J Neurol 2004;251:298-304.
Steinhoff BJ, Zerr I, Glatting M, Schulz-Schaeffer W, Poser S, Kretzschmar HA. Diagnostic value of periodic complexes in Creutzfeldt-Jakob disease. Ann Neurol 2004;56:702-8.
Steinhoff BJ, Racker S, Herrendorf G, Poser S, Grosche S, Zerr I, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996;53:162-6.
Ironside JW, Head MW. Neuropathology and molecular biology of variant Creutzfeldt-Jakob disease. Curr Top Microbiol Immunol 2004;284:133-59.
Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. Data mining, inference and prediction. New York: Springer-Verlag; 2001. p. 299-347.
Breiman L, Friedman JH, Olshen RA, Stone CJ. Classification and regression trees. New York: Chapman and Hall; 1984.
Freund Y, Schapire R. Experiments with a new boosting algorithm, Machine Learning: Proceedings of the Thirteenth International Conference, 1996. p. 148-56.
Breiman L. Arcing classifiers. Annl Stat 1998;26:801-24.
Breiman L. Prediction games and arcing algorithms. Neural Comput 1999;11:1493-517.
Hill AF, Desbrusbais M, Joiner S, Sidle KCL, Gowland J, Collinge L, Doey LJ, Lantos P. The same prion strain causes νCJD and BSE. Nature 1997;389:448-50.
Pals P, Van Everbroeck B, Sciot R, Godfraind C, Robberecht W, Dom R, et al. A retrospective study of Creutzfeldt-Jakob disease in Belgium. Eur J Epidemiol 1999;15:517-9.
Van Everbroeck B, Quoilin S, Boons J, Martin JJ, Cras P. A prospective study of CSF markers in 250 patients with possible Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2003;74:1210-4.
Van Everbroeck B, Boons J, Cras P. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease. Clin Neurol Neurosurg 2005;107:355-60.
Saegerman C, Speybroeck N, Roels S, Vanopdenbosch E, Thiry E, Berkvens D. Decision support tools for clinical diagnosis of disease in cows with suspected bovine spongiform encephalopathy. J Clin Microbiol 2004;42:172-8.
Ihaka R, Gentleman RR. A language for data analysis and graphics. J Comput Graph Stat 1996;5:299-314.
Therneau TM, Atkinson EJ. An introduction to recursive partitioning using the rpart routines. Technical Report 61, Department of Health Science Research, Mayo Clinic, Rochester; 1997.
